Logo Logo
Hilfe
Hilfe
Switch Language to English

Stark, Renee; Kirchberger, Inge; Hunger, Matthias; Heier, Margit; Leidl, Reiner ORCID logoORCID: https://orcid.org/0000-0002-7115-7510; Scheidt, Wolfgang von ORCID logoORCID: https://orcid.org/0000-0003-4740-7783; Meisinger, Christa ORCID logoORCID: https://orcid.org/0000-0002-9026-6544 und Holle, Rolf ORCID logoORCID: https://orcid.org/0000-0001-5395-2695 (2014): Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. In: Clinical Research in Cardiology, Bd. 103, Nr. 3: S. 237-245

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background

Cardiac disease management programmes (CHD-DMPs) and secondary cardiovascular prevention guidelines aim to improve complex care of post-myocardial infarction (MI) patients. In Germany, CHD-DMPs, in addition to incorporating medical care according to guidelines (guideline-care), also ensure regular quarterly follow-up. Thus, our aim was to examine whether CHD-DMPs increase the frequency of guideline-care and whether CHD-DMPs and guideline-care improve survival over 4 years.

Methods

The study included 975 post-MI patients, registered by the KORA-MI Registry (Augsburg, Germany), who completed a questionnaire in 2006. CHD-DMP enrolment was reported by physicians. Guideline-care was based on patient reports regarding medical advice (smoking, diet, or exercise) and prescribed medications (statins and platelet aggregation inhibitors plus beta-blockers or renin-angiotensin inhibitors). All-cause mortality until December 31, 2010 was based on municipal registration data. Cox regression analyses were adjusted for age, sex, education, years since last MI, and smoking and diabetes.

Results

Physicians reported that 495 patients were CHD-DMP participants. CHD-DMP participation increased the likelihood of receiving guideline-care (odds ratio 1.55, 95 % CI 1.20; 2.02) but did not significantly improve survival (hazard rate 0.90, 95 % CI 0.64–1.27). Guideline-care significantly improved survival (HR 0.41, 95 % CI 0.28; 0.59). Individual guideline-care components, which significantly improved survival, were beta-blockers, statins and platelet aggregation inhibitors. However, these improved survival less than guideline-care.

Conclusions

This study shows that CHD-DMPs increase the likelihood of guideline care and that guideline care is the important component of CHD-DMPs for increasing survival. A relatively high percentage of usual care patients receiving guideline-care indicate high quality of care of post-MI patients. Reasons for not implementing guideline-care should be investigated.

Dokument bearbeiten Dokument bearbeiten